Rapid molecular testing for clinical diagnostics
Abacus Diagnostica’s proprietary, fully automated testing platform GenomEra® CDX takes molecular testing to a new level of easiness and speed without compromising the quality of results.
Cost efficient automated solution
All-in-one PCR and RT-PCR test chips with homogeneous detection in fully automated instrument.
Reducing the costs by affordable pricing, robust assays and long service intervals.
CE IVD tests for infectious diseases
Critical human pathogens and antibiotic resistance markers such as C. difficile, Norovirus and MRSA
GenomEra CDX system has proven to be one of the fastest, easiest-to-use and the most cost-effective automated solution for molecular diagnostics (MDx) of infectious diseases. GenomEra is suitable also for small to mid-size customers without any prior experience in MDx.
Our team has been working hard on past weeks and today we shipped first GenomEra SARS-CoV-2 test kits for our customers.
Press-release in Finnish: https://bit.ly/2UvaMC2
Abacus is now on Twitter! We will tweet the latest news and more relaxed stories frequently. Some big news coming next week – stay tuned! https://twitter.com/AbacusCDX #AbacusCDX
Recent publication: GenomEra C. difficile test demonstrates increased reliability for standalone molecular diagnostics
While covid19 is spreading, there are still other worries to deal with. Standalone PCR testing for C. difficile diagnostics is often criticized for overdiagnosis of CDI. In a recent publication (doi:10.1128/JCM.01872-19) GenomEra routine samples were retested with two different toxin immunoassays and discrepant results were confirmed with culture or GeneXpert. Results shows perfect 100% PPV and excellent 99.7% NPV for GenomEra. Study reports insufficient sensitivities of 81.6% and 71.7% for two different toxin immunoassay from ArcDia and TechLab, respectively.